Inventor · disambiguated record
Meredith Suzanne Eno
Also filed as: ENO MEREDITH SUZANNE
5 granted patents·9 pending applications·8 citations·filing 2019–2024
72Inventor score
Top patents by PatentIndex Score
14 records- 0193US11718602B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Granted Aug 8, 2023·2 cites·8 claims
- 0283US10793563B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Oct 6, 2020·3 cites·28 claims
- 0380US10988477B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2019·Granted Apr 27, 2021·3 cites·20 claims
- 0480US2025289801A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2024·Application pending·0 cites
- 0580US2025059190A1Gcn2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2024·Application pending·0 cites
- 0672US12172983B2EGFR inhibitorsBLUEPRINT MEDICINES CORP·Filed 2021·Granted Dec 24, 2024·0 cites·21 claims
- 0762US12084438B2GCN2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2020·Granted Sep 10, 2024·0 cites·25 claims
- 0862US2025236608A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2023·Application pending·0 cites
- 0960US2024382483A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 1059US2022340577A1Gcn2 inhibitors and uses thereofMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 1159US2023019732A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 1258US2024299387A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 1358US2024308981A1Heterocyclic egfr inhibitors for use in the treatment of cancerBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 1458US2024300946A1Egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Meredith Suzanne Eno files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →